Literature DB >> 8480854

Hemoglobin catabolism and host-parasite heme balance in chloroquine-sensitive and chloroquine-resistant Plasmodium berghei infections.

P A Wood1, J W Eaton.   

Abstract

Catabolism of host hemoglobin by the malaria parasite liberates required amino acid precursors, but is also releases large amounts of potentially toxic heme that accumulates in parasite food vacuoles during intra-erythrocytic development. The schizonticidal drug chloroquine binds to free heme with high affinity and is concentrated in parasite food vacuoles. To better understand the disposition of heme within the host-parasite complex, we studied the balance of hemoglobin and heme in Plasmodium berghei-infected reticulocytes in the rat and compared this process in chloroquine-sensitive (CS) and chloroquine-resistant (CR) parasites. We found that CS P. berghei parasites have 1.5-fold more heme than CR parasites isolated from rats, and that CS P. berghei-infected reticulocytes accumulate more chloroquine than CR P. berghei-infected reticulocytes. Despite these differences in parasite heme content, the decrease in host cell hemoglobin content and the rate of free amino acid generation within the host-parasite complex is similar in CS and CR P. berghei-infected rat reticulocytes. The heme content of the infected reticulocyte-parasite complex decreases with increasing parasitemia but to a lesser extent than expected for the decrease in hemoglobin. Furthermore, the decrease in host-parasite heme is accelerated in the CR P. berghei infection compared with the CS P. berghei infection. Therefore, hemoglobin catabolism by malaria parasites is associated with the overall loss of heme from the host-parasite complex and with variable deposition of heme within parasites.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8480854     DOI: 10.4269/ajtmh.1993.48.465

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  6 in total

Review 1.  Plasmodium drug targets outside the genetic control of the parasite.

Authors:  David J Sullivan
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

2.  Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials.

Authors:  P Loria; S Miller; M Foley; L Tilley
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

3.  Revealing parasite influence in metabolic pathways in Apicomplexa infected patients.

Authors:  Tao Xu; Jie Ping; Yao Yu; Fudong Yu; Yongtao Yu; Pei Hao; Xuan Li
Journal:  BMC Bioinformatics       Date:  2010-12-14       Impact factor: 3.169

4.  Evidence for the contribution of the hemozoin synthesis pathway of the murine Plasmodium yoelii to the resistance to artemisinin-related drugs.

Authors:  Benoit Witkowski; Joel Lelièvre; Marie-Laure Nicolau-Travers; Xavier Iriart; Patrice Njomnang Soh; Fatima Bousejra-Elgarah; Bernard Meunier; Antoine Berry; Françoise Benoit-Vical
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

5.  Plasma metabolomics reveals membrane lipids, aspartate/asparagine and nucleotide metabolism pathway differences associated with chloroquine resistance in Plasmodium vivax malaria.

Authors:  Karan Uppal; Jorge L Salinas; Wuelton M Monteiro; Fernando Val; Regina J Cordy; Ken Liu; Gisely C Melo; Andre M Siqueira; Belisa Magalhaes; Mary R Galinski; Marcus V G Lacerda; Dean P Jones
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

6.  Quantitative characterization of hemozoin in Plasmodium berghei and vivax.

Authors:  John M Pisciotta; Peter F Scholl; Joel L Shuman; Vladimir Shualev; David J Sullivan
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-02-08       Impact factor: 4.077

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.